Sign in
4/A

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-001496

Options or other derivatives

  • Director acquired 31,206 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Neal James R Director 2024-09-03 Grant or award · Restricted Stock +31,206 36,275 D
Loading xslF345X05/form4.xml…